Navigation Links
Intercell AG Partners with Inclinix to Enroll 1800 Volunteers for Phase III Travelers' Diarrhea Vaccine Study
Date:1/19/2009

WILMINGTON, N.C., Jan. 19 /PRNewswire/ -- Intercell AG has retained Inclinix, Inc., to recruit volunteers for their Phase III clinical trial of a Travelers' Diarrhea (TD) vaccine system. The TD vaccine is in the form of a skin patch -- a novel method for delivering a vaccine that is especially compelling because it is needle-free.

This year, approximately 55 million international travelers will visit countries where bacteria that cause TD are endemic, particularly Africa, Asia and Latin America, and nearly 20 million of those travelers develop TD. The effects extend beyond the acute symptoms of the disease; between 10 and 30 percent of those who develop TD will develop the chronic symptoms of irritable bowel syndrome. If approved, this would be the first vaccine for TD available in the US.

Inclinix, a Wilmington, NC-based clinical trial enrollment solutions provider, will utilize its innovative recruitment tactics to drive the enrollment of 1200 volunteers in the US and 600 in Western Europe beginning in April 2009.

"We are pleased that Intercell AG has chosen Inclinix as their partner for the TD study," says J. Tobin Geatz, President and CEO, Inclinix. "We look forward to the opportunity to contribute to the development of this novel drug that has potential to make a truly global impact on the medical community."

The recruitment strategy for this study, appropriately named the "Trek Study" (www.TrekStudy.com), centers on reaching out to specific groups most likely to respond to free travel to Mexico or Guatemala while focusing on the social and altruistic impacts of clinical trial participation.

In order to build awareness of the Trek Study, Inclinix has developed partnerships with major travel and tourism websites. In addition, Recruitment Monitors -- in-field enrollment experts -- will execute events in commun
'/>"/>

SOURCE Inclinix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
2. Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection
3. Favourable Six Months Follow-Up Results From Intercells Phase II Therapeutic Hepatitis C Program
4. USD 12.5 m Funding for the Development of Intercells Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS)
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
10. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
11. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... , Nov. 24, 2014 The Female Health ... an investor conference call to discuss its operating results ... 30, 2014 on Tuesday, December 2, 2014 at 11:00 ... report its operating results earlier the same day. ... the conference call by dialing 1-877-374-8416 (international participants dial ...
(Date:11/24/2014)... 24, 2014  GlySens Incorporated announced today that it ... from the National Institute of Diabetes and Digestive and ... of Health (NIH).  The grant is intended to support ... long term implantable glucose monitoring system.  Final preparations for ... expected to begin before the end of 2014. ...
(Date:11/24/2014)... , Nov. 24, 2014  Pifflers United ... announced the release of results of a ... device, in the self-management of fibromyalgia pain. The ... of worst pain, very significant clinically meaningful pain ... 140 group members with fibromyalgia used ActiPatch® for ...
Breaking Medicine Technology:The Female Health Company To Report FY2014 Operating Results on Tuesday, December 2, 2014 2GlySens Incorporated Awarded $2 Million Grant from the National Institutes of Health 2Pifflers United - "Supporting Anyone Living With Chronic/Invisible Illness" Reports ActiPatch Bioelectronic Therapy Relieves Chronic Pain In Fibromyalgia 2Pifflers United - "Supporting Anyone Living With Chronic/Invisible Illness" Reports ActiPatch Bioelectronic Therapy Relieves Chronic Pain In Fibromyalgia 3
... , ST. PAUL, Minn. , ... take ibuprofen may reduce their risk of developing Parkinson,s disease, according to ... Academy of Neurology ,s 62nd Annual Meeting in Toronto ... people who did not have Parkinson,s disease at the beginning of the ...
... , , CAGLIARI, Italy , Feb. ... than 4500 patients from six Italian EVEREST (European Vertebroplasty Research ... , Dr. P. Carpeggiani-Pisa, Dr. S. Masala-Roma , Dr. ... treating vertebral compression fractures (VCFs), finding that the procedure provides ...
Cached Medicine Technology:An Ibuprofen a Day Could Keep Parkinson's Disease Away 2Multi-Center Data in a Large Series of Patients Show Vertebroplasty Provides Dramatic and Lasting Pain Relief for Vertebral Compression Fractures 2Multi-Center Data in a Large Series of Patients Show Vertebroplasty Provides Dramatic and Lasting Pain Relief for Vertebral Compression Fractures 3Multi-Center Data in a Large Series of Patients Show Vertebroplasty Provides Dramatic and Lasting Pain Relief for Vertebral Compression Fractures 4
(Date:11/23/2014)... For the coming special Friday, Tidebuy, a ... great promotion for many products, especially the beautiful colored ... best choice with amazing discounts, up to 90% off. ... It is easy to buy colored wedding dresses in ... is also famous for delicate craftsmanship, elegant style and ...
(Date:11/23/2014)... November 23, 2014 Pro Ace Care, a ... it will now be providing an 8 year warranty on ... water tank installations went up due to the impending winter ... its customers of the premium service that the company provides. ... year warranty on John Wood and Bradford hot water tanks. ...
(Date:11/23/2014)... SUNDAY, Nov. 23, 2014 (HealthDay News) -- The holidays ... autism because sensory overload can trigger major meltdowns, an ... under the best of circumstances, but when you have ... Varleisha Gibbs, an occupational therapy professor at University of ... release. "It,s best to let your hosts or ...
(Date:11/23/2014)... show thanks to new and old customers, iFitDress.com has ... for weddings. Customers who need custom outfits can talk ... dress manufacturer, and it is among the ones which have ... long time. The CEO of this company says, "iFitDress.com is ... buy not only a beautiful dress, but also a piece ...
(Date:11/23/2014)... AngelWeddingDress.com has recently updated its online store, ... dresses. “If you are looking for gorgeous beach wedding ... possible. Here you can enjoy 70% off discounts and ... a big marriage ceremony is the most important dream ... dress is uppermost priority. Ophelia, one of customers, said, ...
Breaking Medicine News(10 mins):Health News:Beautiful Wedding Dresses Available at Popular B2C Company Tidebuy 2Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2Health News:Holidays Can Be Sensory Overload for Kids With Autism 2Health News:iFitDress.com: Wonderful White Evening Dresses Now Available 2Health News:Beach Wedding Dresses Added to Outstanding Online Dress Company AngelWeddingDress.com 2
... pressure, two conditions rooted in genetics and environmental surroundings, ... determining// who is mostly likely to develop heart failure, ... Americans die from heart failure. ,Experts ... exist in who actually develops risk factors for the ...
... A recent study conducted on the pneumococcal conjugate vaccine, administered ... diseases, has helped reduce hospitalizations among children due to pneumonia. ... it is important for all U.S. children to get four ... in the age group of 2-5, who have missed out ...
... eat apples during pregnancy may protect their children from developing ... Netherlands and Scotland tracked dietary intake by nearly 2,000 pregnant ... airway development in more than 1,200 of their children five ... consumed and recorded by the pregnant women, the researchers found ...
... 7 th of April every year. ... World Health Organization. //The primary role of the World Health Day ... universal awareness. The theme for the year 2007 is, ... world governments, business sectors and other non- governmental organizations to ‘invest ...
... United Biotech is diversifying into the oncology segment starting ... an initial// investment of $3.4 million. ... oncology at its facility in Baddi, Himachal Pradesh (India). ... Blausiegel, a Brazilian company, for its entire range of ...
... nutrition in children could lead to confusion and a cut ... programs, warn researchers in this week’s BMJ. ,According ... emergencies has risen over the last twenty years, from an ... than 30 per year since 2000. In 2005, around 73 ...
Cached Medicine News:Health News:Race Takes Back Seat to Diabetes and High Blood Pressure 2Health News:Race Takes Back Seat to Diabetes and High Blood Pressure 3Health News:'Invest in Health, Build a Safer Future': World Health Day 2Health News:New Standards Could Cut Number of Malnourished Children on Feeding Programs 2
Intermittent catheter...
Intermittent catheter...
Intermittent catheter...
The SJM Sguin annuloplasty ring, a semi-rigid ring, is constructed of a one-piece solid core of ultra-high-weight polyethylene enclosed in a knitted polyester sewing cuff....
Medicine Products: